• AMYLIN PHARMACEUTICALS INC Financial Overview

  • Income Statement: AMLN

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 781.00 M 510.88 M 270.12 M 34.59%
    Gross Profit 715.54 M 444.57 M 270.97 M 37.87%
    Net Income Before Extra Items/Preferred Div -211.14 M -218.86 M 7.72 M -3.66%
    Operating Income -242.98 M -237.39 M -5.58 M 2.30%
  • Cash Flow: AMLN

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing 776.85 M 546.51 M 230.34 M 29.65%
    Net Cash Flow - Investing 296.10 M 425.89 M -129.79 M -43.83%
    Net Cash Flow/Operating Activities -125.16 M -126.01 M 847,000.00 -0.68%
  • Balance Sheet: AMLN

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 1.77 B 1.06 B 713.82 M 40.23%
    Total Liabilities 1.22 B 425.10 M 796.30 M 65.20%
    Shareholders Equity 552.82 M 635.29 M -82.47 M -14.92%
  • Key Ratios / Statistics: AMLN

    • Valuation

      Price/Earnings (TTM) -23.27
      Price/Sales (TTM) 6.28
      Price/Book (MRQ) 6.89
      Price/Cash Flow (TTM) -10.46
    • Profitability

      Gross Margin 91.62
      Operating Margin -31.11
      Profit Margin -27.03
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 4.21
      Current Ratio (MRQ) 4.19
      Long Term Debt-to-Equity (MRQ) 174.96
    • Management Effectiveness

      Return on Equity (TTM) -35.48
      Return on Assets (TTM) -14.21
      Return on Investments (TTM) -17.60